Tivic Health regains Nasdaq minimum bid price compliance; stock continues listing

Valion Bio, Inc.

Received Nasdaq confirmation on April 4, 2025 that minimum bid price compliance is regained.
Reverse stock split implemented on March 7, 2025 as required by Nasdaq Hearings Panel.
Company had been notified of deficiency in June 2024 and received extension through panel decision.
Common stock (TIVC) continues trading on Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.